Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trickle Portfolio -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (924)	12/3/2001 12:15:59 PM
From: nigel bates	Respond to of 1784

Agilent Laboratories Announces $6.1 Million DARPA Collaboration to Develop Breakthrough DNA Synthesis Process PALO ALTO, Calif.--(BW HealthWire)--Dec. 3, 2001-- Agilent Laboratories, the central research facility of Agilent Technologies Inc. (NYSE: A - news), today announced a collaboration with The University of Colorado and DARPA, the Defense Advanced Research Projects Agency to develop a breakthrough two-step process for the chemical synthesis of nucleic acids. The $6.1 million collaboration includes joint funding by Agilent and DARPA and could potentially double the speed of DNA synthesis critical to disease characterization and drug discovery. The two-step process would represent the first major breakthrough in the synthesis of nucleic acids in 20 years. The current approach was developed by Marvin Caruthers and his co-workers at the University of Colorado more than 20 years ago. Agilent expects the technology to provide significant reductions in the complexity, time required, and cost to manufacture its DNA microarrays. More broadly, for biomedical researchers and healthcare professionals, the speed and simplicity of this new technology is expected to expand access to genetic information for use in drug discovery and development, as well as prediction, diagnosis and treatment of disease in the laboratory and in the field. Nucleic acids such as DNA contain the blueprints for all living organisms. The ability to chemically synthesize nucleic acids is fundamental to the wide range of life science research efforts -- from nucleic acid amplification, to sequencing and detection. The two-step process would simplify the chemistry used to synthesize nucleic acids, reduce the number of synthesis steps from four to two, eliminate most of the highly toxic reagents and solvents used in the current process, and reduce chemical waste by 75 percent. Because the technology is simpler than existing technology, it could be potentially faster, more reliable, and more suitable for chip-sized miniaturization and highly parallel batch processing. A team led by principle investigator Doug Dellinger, Ph.D., of Agilent Labs will perform the research in collaboration with Caruthers, a distinguished professor with the University of Colorado's Department of Chemistry and Biochemistry. By participating in the commercialization of DNA synthesis in the late 1970s and early 1980s, Caruthers helped fuel the biotechnology revolution, and is considered a pioneer and inventor of the chemistry used for automated DNA synthesis. ``This agreement enables the Labs to pursue alternative solutions to a technological problem which would accelerate the problem-solving process,'' said Tom Saponas, senior vice president, chief technology officer and director of Agilent Labs. ``This agreement provides Agilent Labs with the additional funding needed to develop this early-stage invention to the point that it can be transferred to Agilent's life sciences business for incorporation into Agilent's manufacturing processes and future products.'' About DARPA The Defense Advanced Research Projects Agency (DARPA) is the central research and development organization for the Department of Defense (DoD). It manages and directs selected basic and applied research and development projects for the DoD, and pursues research and technology where risk and payoff are both very high and where success may provide dramatic advances for traditional military roles and missions. About Agilent Laboratories Agilent Laboratories, formerly part of Hewlett-Packard Laboratories, is one of the leading technological research centers in the world. Based in Palo Alto, Calif., Agilent Labs draws on the talents of more than 430 researchers and support staff. The Labs conduct applied research in communications, electronics, healthcare, the life sciences, and measurement; fundamental research in bioscience, fiber optics, materials, microelectronics, micromechanical systems, and optoelectronics; and basic research. Agilent Labs is focused on driving growth and profit for Agilent's businesses through technology innovation. Information about Agilent Laboratories can be found at www.labs.agilent.com.